Considerations for the optimal management of antibiotic therapy in elderly patients.


Journal

Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459

Informations de publication

Date de publication:
09 2020
Historique:
received: 02 02 2020
revised: 14 02 2020
accepted: 26 02 2020
pubmed: 14 3 2020
medline: 24 6 2021
entrez: 14 3 2020
Statut: ppublish

Résumé

To maximise efficacy and minimise toxicity, special considerations are required for antibiotic prescription in elderly patients. This review aims to provide practical suggestions for the optimal management of antibiotic therapy in elderly patients. This was a narrative review. A literature search of published articles in the last 15 years on antibiotics and elderly patients was performed using the Cochrane Library and PubMed electronic databases. The three priority areas were identified: (i) pharmacokinetics/pharmacodynamics (PK/PD) for optimising dosage regimens and route of administration; (ii) antibiotic dosages in some special subpopulations; and (iii) treatment considerations relating to different antibiotic classes and their adverse events. Clinicians should understand the altered PK/PD of drugs in this population owing to co-morbid conditions and normal physiological changes associated with ageing. The body of evidence justifies the need for individualised dose selection, especially in patients with impaired renal and liver function. Clinicians should be aware of the major drug-drug interactions commonly observed in the elderly as well as potential side effects. Antibiotic therapy in the elderly requires a comprehensive approach, including strategies to improve appropriate antibiotic prescribing, limit their use for uncomplicated infections and ensure the attainment of an optimal PK/PD target. To this purpose, further studies involving the elderly are needed to better understand the PK of antibiotics. Moreover, it is necessary to assess the role therapeutic drug monitoring in guiding antibiotic therapy in elderly patients in order to evaluate its impact on clinical outcome.

Identifiants

pubmed: 32165285
pii: S2213-7165(20)30051-5
doi: 10.1016/j.jgar.2020.02.022
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-333

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Marco Falcone (M)

Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, Pisa 56124, Italy. Electronic address: marco.falcone@unipi.it.

Mical Paul (M)

Division of Infectious Diseases, Rambam Health Care Center and The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Giusy Tiseo (G)

Department of Clinical and Experimental Medicine, University of Pisa, Via Paradisa 2, Pisa 56124, Italy.

Dafna Yahav (D)

Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Virginie Prendki (V)

Division of Internal Medicine of the Aged, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and University of Geneva, Hôpital des Trois-Chêne, Geneva, Switzerland.

Lena E Friberg (LE)

Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

Roberto Guerri (R)

Infectious Diseases Department, Hospital del Mar, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Gaetan Gavazzi (G)

University Clinics of Geriatrics, University Hospital of Grenoble-Alpes, GREPI EA7408 University of Grenoble Alpes, Grenoble, France.

Cristina Mussini (C)

Clinic of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.

Marco Tinelli (M)

Division of Infectious and Tropical Diseases, Hospital of Lodi, Lodi, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH